Released May 8, 2020, before the open
10-Q filed May 8, 2020, 38 days after period end · 0001564590-20-023255
Q1 2020 · 10-Q
Revenue$104.82M$104.82M −3.9% vs Q1 2019−13.7% vs Q4 2019
Net Income$25.67M$25.67M +2,761.2% vs Q1 2019+119.6% vs Q4 2019
EPS Diluted$1.32$1.32 +2,540.0% vs Q1 2019+120.0% vs Q4 2019
Gross Profit$81,414,000−4.7%
Operating Income$6,854,000N/M
Operating Cash Flow$12,464,000N/M
Free Cash Flowderived$8,179,000N/M
Margins · derived
Gross margin77.7%−0.6 pt vs Q1 2019
Operating margin6.5%+10.6 pt vs Q1 2019
Net margin24.5%+23.7 pt vs Q1 2019
What the release said
The release
Same quarter
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $104.82M | $109.11M | $108.71M | $102.74M |
| Net Income | $25.67M | $897.00K | $5.23M | -$2.65M |
| EPS Diluted | $1.32 | $0.05 | $0.27 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR